Clinical Research Directory
Browse clinical research sites, groups, and studies.
Comparison of Efficacy in SBRT of Large HCC With or Without TACE
Sponsor: Beijing 302 Hospital
Summary
The study aims to compare efficacy and adverse reactions of large hepatocellular carcinoma participants (5-10cm) who receive stereotactic body radiation therapy with or without transcatheter arterial chemoembolization.The investigators will optimize the combined treatment schedule of SBRT for hepatocellular carcinoma participants by comparing overall survival rates, progression-free survival rates and local control and adverse reaction occurrence rates in the two groups.
Official title: Comparison of Efficacy in Stereotactic Body Radiation Therapy (SBRT) of Large Hepatocellular Carcinoma (5-10 cm) With or Without Transcatheter Arterial Chemoembolization (TACE)
Key Details
Gender
All
Age Range
30 Years - 80 Years
Study Type
OBSERVATIONAL
Enrollment
100
Start Date
2020-08-01
Completion Date
2026-08-30
Last Updated
2023-06-27
Healthy Volunteers
No
Conditions
Locations (1)
Beijing 302 hospital
Beijing, China